CraniUS Therapeutics

NeuroPASS™ by CraniUS Therapeutics is designed to provide unprecedented precision in drug delivery. By bypassing the blood-brain barrier, it aims to deliver medication directly to the brain at a controlled flow rate, eliminating systemic side effects and enhancing treatment effectiveness. This level of accuracy has the potential to change the way we approach treatments for challenging conditions like brain tumors, Alzheimer’s, and Parkinson’s. #Innovation #NeuroPASS #CraniUSTherapeutics #BrainHealth #DrugDelivery CAUTION: Investigational Device. Limited by Federal (or United States) law to investigational use.

Dr. Chad Gordon from Johns Hopkins and Founder and CMO of CraniuUS Therapeutics will be presenting the NeuroPASS System at the 9th Annual Neuroplastic & Reconstruction Surgery on Dec 7-8 in Miami, FL. Join us for his talk and hands-on training in the cadaver lab to explore the latest advancements in Neuroplastic Surgery. #CraniUS #NeuroPass #NeuroplasticSurgery #SurgicalInnovation #MedicalTraining #JohnsHopkins Johns Hopkins Medicine Global Neuro Foundation

We’re thrilled to attend the 6th CNS Drug Delivery Summit and connect with leading innovators in neuroscience and drug delivery. This summit highlights groundbreaking advancements in blood-brain barrier transport, CSF administration, and device-mediated therapies that are reshaping CNS drug development. Let’s connect and explore opportunities to collaborate—see you there! #CNSDrugDelivery #CraniUSTherapeutics #InnovationInNeuro #MedicalAdvancement #DrugDeliverySolution International Society for CNS Drug Development (ISCDD)

Tomorrow’s the day! Don’t miss Michael Maglin from CraniUS presenting at the Medtech Innovation Summit on Wednesday, November 20th, at 9:35 AM. He’ll share groundbreaking insights on NeuroPass™ technology—our innovative solution for targeted drug delivery in neurological conditions like brain tumors, Alzheimer’s, and Parkinson’s disease. Join us to discover how this cutting-edge technology is redefining the future of treatment. #MedTechSummit #CraniUS #NeuroPass #HealthcareInnovation #InnovationInSanDiego

Exciting News! On Wednesday, November 20th at 9:35 AM, Michael Maglin from CraniUS will be presenting at the Medtech Innovation Summit! He’ll dive into the latest advancements in NeuroPass™ technology, our innovative approach in targeted drug delivery for neurological conditions including brain tumors, Alzheimer’s, and Parkinson’s disease. Join us as we explore how this breakthrough could reshape the treatment landscape. Don’t miss it! #MedTechSummit #CraniUS #NeuroPass #InnovationInHealthcare #innovationsandiego Michael Maglin MedTech Strategist

MedTech Strategist is honored to welcome CraniUS alongside CEO Michael Maglin as a Presenting Company at Innovation Summit San Diego 2024. Presenting in the Neuromodulation-Neurostimulation and Drug Delivery Therapeutic Categories, NeuroPass™ from CraniUS (Baltimore, MD, USA) is a groundbreaking, fully implantable drug delivery system that bypasses the blood-brain barrier, enabling targeted and long-term therapeutic delivery directly to brain tissue. Welcome to #InnovationSanDiego, Michael and CraniUS! 🤝 Climb the Summit to San Diego November 19-21, 2024: https://bit.ly/4gBjKW6 #medicaldevices #startups #drugdelivery #medtechinnovation #medtech #neuromodulation #neurostimulation #drugdeliverysystem #remotemanagement

We are thrilled to announce that CraniUS™ has been awarded a competitive $1 million grant from the State of Maryland's Build Our Future Innovation Infrastructure Program! This funding will help advance our transformative skull-embedded medicine delivery technology designed to revolutionize brain disease treatment by bypassing the blood-brain barrier.  Our NeuroPass™ therapeutic delivery system has the potential to impact the lives of millions of patients suffering from diseases including Glioblastoma, Alzheimer’s, and Parkinson’s Disease.   Thank you, Governor Wes Moore and the State of Maryland, for fostering innovation and supporting our mission. Together, we're on the path to creating life-changing neurotechnology solutions!  Read the full press release: https://lnkd.in/e6aB6d6v #Medicaldevices #Neurotechnology #BrainHealth #glioblastomaawarness #AlzheimersResearch #ParkinsonsDisease Gov. Wes Moore

CraniUS™ Awarded Competitive $1 Million Grant from the State of Maryland’s Build Our Future Innovation Infrastructure Program #Medicaldevices #Neurotechnology #BrainHealth #glioblastomaawarness #AlzheimersResearch #ParkinsonsDisease https://bit.ly/3VHlZxz

Breaking Barriers in Drug Delivery! Thrilled to share a glimpse into the future of medicine with CraniUS CEO, Michael Maglin! In an insightful interview hosted by Stephen M. Perry, Kymanox CEO, we explore our innovative drug delivery platform, set to redefine possibilities beyond the blood-brain barrier. Big thanks to Chris Frew of BioBuzz for capturing our journey in a must-read article and to Stephen Perry for steering the conversation toward groundbreaking advancements! Read the full article here: https://lnkd.in/eSxGrRPZ Join us in celebrating the fusion of visionaries pushing the boundaries of medical science!  #DrugDelivery #Medicalinnovation #CraniUS #BioBuzz #Kymanox #HealthcareAdvancements #BeyondBoundaries

Warmest wishes from CraniUS! This holiday season, we're grateful for your support and excited for the opportunities the new year holds. Cheers to joy, laughter, and continued success! 🎄🎁 #HappyHolidays #CraniUS